SMARCA4 controls state plasticity in small cell lung cancer through regulation of neuroendocrine transcription factors and REST splicing
Esther Redín(Memorial Sloan Kettering Cancer Center), Charles M. Rudin(Memorial Sloan Kettering Cancer Center)
Cited by 32
Related Papers
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
|New England Journal of Medicine|2009|1k
Targeted Therapies and Biomarkers in Small Cell Lung Cancer
|Frontiers in Oncology|2020|112
Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation
|Journal of Hematology & Oncology|2021|92
Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers
|Science Translational Medicine|2023|44
Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228
|Journal of Thoracic Oncology|2022|35